source
- Novartis weighs private-pay launches in Europe as MFN rules pressure government pricingNovartis CEO Vas Narasimhan said the company is exploring the option of introducing new medicines directly to private or self‑pay patients in Europe. The discussion is driven by the European Union…
- Federal judge denies Novo's attempt to block Eli Lilly obesity drug adsA federal judge in the U.S. District Court denied Novo Nordisk's request to halt an Eli Lilly advertising campaign that compared the two companies' obesity treatments, Wegovy and Zepbound. Novo ar…